Kang Yu, Ph.D., graduated from the University of Alberta in 2020. During his doctoral studies, Dr. Yu focused on the function and gene regulation of a receptor called LILRB1 in Natural Killer (NK) cells. He then moved to the City of Hope National Medical Center in Duarte, California as a postdoctoral fellow exploring novel regulatory pathways in NK cells in response to cancer cells using CRISPR screening techniques.

Dr. Yu’s current research focuses on how super-enhancers and non-coding RNA modulate immune regulator genes and the implications in lymphocyte development, differentiation, and activation.